Team:Wageningen UR/Experimental protocols

From 2013.igem.org

(Difference between revisions)
(Materials)
Line 16: Line 16:
<html>
<html>
<p>
<p>
-
Standard lab procedures are explained in Appendix A, B, C and D. Novel protocols are mentioned and explained at the specific topic pages, since they cannot be explained without the mention of intermediate results and can be considered results.
+
Standard lab procedures are explained in Appendix A, B, C and D. Novel protocols are mentioned and explained at the specific topic pages, since they cannot be explained without the mention of intermediate results and can be considered results. A detailed version of these protocols is also given here.
</p>
</p>
 +
</html>
 +
==Strains==
 +
<html>
 +
<p>
 +
<u><i>A. niger</i> N593<u><br />
 +
This strain is cspA and pyrA deficient. Media for N593 are supplemented with 5 mM uridine. Unlike citric acid producers, this strain produces mainly oxalic acid.
 +
</p>
 +
</html>
</html>
<!--- Footer Template --->
<!--- Footer Template --->
{{:Team:Wageningen_UR/Templates/Page Footer}}
{{:Team:Wageningen_UR/Templates/Page Footer}}

Revision as of 22:03, 11 September 2013

  • Lablog
  • Experimental protocols

Protocols

Subtitle

Materials

Standard lab procedures are explained in Appendix A, B, C and D. Novel protocols are mentioned and explained at the specific topic pages, since they cannot be explained without the mention of intermediate results and can be considered results. A detailed version of these protocols is also given here.

Strains

A. niger N593
This strain is cspA and pyrA deficient. Media for N593 are supplemented with 5 mM uridine. Unlike citric acid producers, this strain produces mainly oxalic acid.